Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.078 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |